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1. INTRODUCTION 
 Cancer is an enormous global health burden, touching every region and 
socioeconomic group. Tobacco use is a major cause of the increasing global burden of 
cancer as the number of smokers worldwide continues to grow
[1]
.  
 
 World wide cancer incidence and mortalitystatistics are taken from the 
International Agency for Research on Cancer GLOBOCAN database and also the World 
Health Organisation, Global Health Observatory and the United Nations World 
Population Prospects report
[2]
. 
 
 In 2008 approximately 12.7million cancers were diagnosed (excluding non-
melanoma skin cancers and other non-invasive cancers). In 2010 nearly 13.98 
million cancers were diagnosed. In 2012, an estimated 14.1 million new cases of 
cancer occurred worldwide. More than half of cancers occurring worldwide are 
in less developed regions.  
 
 The four most common cancers occurring worldwide are lung, female breast, 
bowel and prostate cancer. These four cancers account for around 4 in 10 of all 
cancers diagnosed worldwide.  
 
 Lung cancer is the most common cancer in men worldwide. More than 1 in 10 of 
all cancers diagnosed in men is lung cancers. It accounts 1.4 million deaths in 
worldwide. 
 
  
 In 2010 nearly 7.98 million people died with cancer. In 2012, estimated 8.1 
million people died from cancer worldwide. More than 6 in 10 cancer deaths 
worldwide occur in less developed regions of the world 
[3]
. 
 The Society’s Global Health and Intramural Research departments are raising 
awareness about the growing global cancer burden and promoting evidence-based cancer 
and tobacco control programs.  
            The Society has established key focus areas help to reduce the global burden of 
cancer, including global grassroots policy and awareness, tobacco control, cancer 
screening and vaccination for breast and cervical cancers, access to pain relief and the 
support of cancer registration in low and middle-income countries 
[4,5]
. 
 
Cancer in India 
Cancer rates in India are considerably lower than those in more developed countries 
such as the United States data from population based cancer registries in India show that 
the most frequently reported cancer sites in males are lung, oesophagus, stomach, and 
larynx. In females, cancers of the cervix, breast, ovary and oesophagus are the most 
commonly encountered 
[6]
. 
 
 India officially recorded over half a million deaths due to cancer in 2011 – 
5.35 lakhs as against 5.24 lakhs in 2010 and 5.14 lakhs in 2009. 
 The estimated number of new cancers in India per year is about 7 lakhs and 
over 3.5 lakhs people die of cancer each year. Out of these 7 lakhs new 
cancers about 2.3 lakhs (33%) cancers are tobacco related. 
  
 In India, which has nearly three million patients suffering from the disease. 
Annually, nearly 500,000 people die of cancer in India. The WHO said this 
number is expected to rise to 700,000 by 2015
[7,8]
 
 
As per WHO, 
 Cancer is the leading cause of death worldwide, accounting for 7.6 million 
deaths in 2008. 
 Lung, stomach, liver, colon, breast cancer cause the most cancer deaths 
each year. 
 About 30% of cancer deaths are due to the behavioural and dietary risks, 
 High BMI 
 Low fruit and vegetable 
 Lack of physical activity 
 Tobacco use 
 Alcohol use 
 
 Death from cancer worldwide are projected to continue rising with an 
estimated 13.1million deaths in 2030. 
 The risk of developing cancer generally increases with age and mass 
lifestyle changes occur in the developing world 
[9, 10]
. 
 
Cervical Cancer 
Cervical cancer is the most commonly occurring cancer in females. About 70% 
of cervical cancers occur in developing countriesWorldwide, cervical cancer is both the 
fourth-most common cause of cancer and the fourth-most common cause of death from 
  
cancer in women. In 2012, an estimated 528,000 cases of cervical cancer occurred, with 
266,000 deaths. This is about 8% of the total cases and total deaths from cancer. 
In India, the numbers of people with uterine cervix cancer are rising, but overall 
the age-adjusted rates are decreasing. Improvement of education in the female 
population has improved the survival of women with cancers of uterine cervix
[11]
.  
 Cervical cancer is a cancer arising from the cervix. It is due to the abnormal 
growth of cells that have the ability to invade or spread to other parts of the body. Early 
on, typically no symptoms are seen. Later symptoms may include abnormal vaginal 
bleeding, pelvic pain, or pain during sexual intercourse. While bleeding after sex may 
not be serious, it may also indicate the presence of cervical cancer
[12]
.
 
 Human papilloma virus (HPV) infection appears to be involved in the 
development of more than 90% of cases. Cervical cancer may be benign or malignant. 
Benign tumor is not life threatening and non- invasive but, malignant tumor is life 
threatening and invasive
[13]
. 
Causes of Cervical cancer  
 In most cases, cells infected with the HPV virus heal on their own. In some 
cases, however, the virus continues to spread and becomes an invasive cancer. 
High-risk HPV types may cause cervical cell abnormalities or cancer. More than 
70% of cervical cancer cases can be attributed to two types of the virus, HPV-16 and 
HPV-18, often referred to as high-risk HPV types. 
A woman with a persistent HPV infection is at greater risk of developing cervical 
cell abnormalities and cancer than a woman whose infection resolves on its own. Certain 
  
types of this virus are able to transform normal cervical cells into abnormal ones, these 
abnormal cells develop in to cervical cancer 
[14]
.
 
Symptoms of Cervical Cancer 
 Precancerous cervical cell changes and early cancers of the cervix generally do 
not cause symptoms. For this reason, regular screening through Pap and HPV tests can 
help catch precancerous cell changes early and prevent the development of cervical 
cancer 
[15]
. 
 Possible symptoms of more advanced disease may include abnormal or irregular 
vaginal bleeding, pain during sex, or vaginal discharge. Notify your healthcare provider 
if you experience: 
 Abnormal bleeding, such as  
o Bleeding between regular menstrual periods 
o Bleeding after sexual intercourse 
o Bleeding after douching 
o Bleeding after a pelvic exam 
o Bleeding after menopause 
 Pelvic pain not related to your menstrual cycle 
 Increased urinary frequency 
 Heavy or unusual discharge that may be watery, thick, and possibly have a foul 
odour 
 Pain during urination 
  
 These symptoms could also be signs of other health problems, not related to 
cervical cancer. If you experience any of the symptoms above, talk to a healthcare 
provider
[16]
.  
Dalton's lymphoma ascites 
  Experimental tumor models have a wide role in anticancer drug discovery. A 
Dalton’s lymphoma ascites (DLA) tumorigenesis model in Swiss albino mice provides a 
convenient model system to study antitumor activity within a short time. 
 The Dalton's tumor has been used as a transplantable tumor model to investigate 
the anti-neoplastic effects of several molecules and compounds. Following 
intraperitonial inoculation of Dalton's tumor cells, the ascetic volume and number of 
tumor cells increase progressively (Vincent and Nicholls, 1967). Ascitics is probably 
formed in consequence of tumor-induced inflammation due to the increase in peritoneal 
vascular permeability (Fastaia and Dumont, 1979). Another hypothesis argues that 
ascitis may be formed as a consequence of the impaired peritoneal lymphatic vessels 
drainage. Mice bearing the ascetic tumor, die after a short period of time due to several 
factors. They are 
 Mechanical pressure exerted by the progressive increase of ascetic fluid. 
 Intraperitoneal haemorrhage. 
 Endotoxemia (Hartveit, 1965) [17]. 
 
Treatment 
 Many treatment are available for cancer exist, with the primary once including 
chemotherapy, surgery, hormonal therapy, radiation therapy, targeted therapy and 
  
palliative care. Which treatments are used depends upon the type, location and grade of 
the cancer as well as the person's health and wishes. The treatment intent may be 
curative or not curative 
[18]
. 
Chemotherapy  
            Chemotherapy is the treatment of cancer with one or more cytotoxic anti-
neoplastic drugs (chemotherapeutic agents) as part of a standardized regimen. The term 
encompasses any of a large variety of different anticancer drugs, which are divided into 
broad categories such as alkylating agents and antimetabolites. Traditional 
chemotherapeutic agents act by killing cells that divide rapidly one of the main 
properties of most cancer cells
[19]
. 
Surgery  
            Surgery is the primary method of treatment of most isolated solid cancers and 
may play a role in palliation and prolongation of survival. It is typically an important 
part of making the definite diagnosis and staging the tumour as biopsies are usually 
required. In localized cancer surgery typically attempts to remove the entire mass along 
with, in certain cases, lymph nodes in the area. For some types of cancer this is all that is 
needed to eliminate the cancer 
[20]
.  
Radiation  
           Radiation therapy involves the use of ionizing radiation in an attempt to either 
cure or improve the symptoms of cancer. It works by damaging the DNA of cancerous 
tissue leading to cellular death. As with chemotherapy, different cancers respond 
differently to radiation therapy
[21]
. 
 
 External Beam Radiation , which is well tested, long lasting treatment option 
  
 Internal Beam Radiation (implantation of radioactive seeds), which is 
recently developed, shorter treatment interval, focused to the            affected 
area 
[22]
. 
Palliative care  
            Palliative care refers to treatment which attempts to make the person feel better 
and may or may not be combined with an attempt to treat the cancer. Palliative care 
includes action to reduce the physical, emotional, spiritual and psycho-social distress 
experienced by people with cancer 
[23]
. 
           People at all stages of cancer treatment should have some kind of palliative care 
to provide comfort. In some cases, medical especially professional organizations 
recommend that people and physicians respond to cancer only with palliative care and 
not with cure-directed therapy 
[24]
. 
Hormonal Therapy 
             It is given for the patients with hormone receptor-positive cancers. It is used to 
reduce the amount of estrogen or block its action to reduce the risk of recurrence at the 
early stage of the disease and to shrink or slow down the growth of existing tumor at the 
stage of the disease. Hormone therapy includes, 
 Aromatase inhibitors -  Latrazole, Anastrazole 
 Selective estrogen 
receptor modulators            - Tamoxifen, Tormifene
[25] 
 
Immunotherapy  
            A variety of therapies using immunotherapy, stimulating or helping the immune 
system to fight cancer, have come into use since 1997, and this continues to be an area 
of very active research 
[26]
. 
  
 Today plant based drugs continue to play an essential role in health care. It has 
been estimated by the World Health Organization that 80% of the population of the 
world rely mainly on traditional medicines for their primary health care. Natural 
products also play an important role in the health care of the remaining 20% people of 
the world, who mainly reside in developed countries. Currently at least 119 chemicals, 
derived from 90 plant species, can be considered as important drugs in one or more 
countries. Studies in 1993 showed that plant-derived drugs represent about 25% of the 
American prescription drug market and over 50% of the most prescribed drugs in the US 
had a natural product either as the drug or as the starting point in the synthesis or design 
of the agent 
[27]
. 
 
  There are more than 250,000 species of higher plants in the world, and almost 
every plant species has a unique collection of secondary constituents distributed 
throughout its tissues. A proportion of these metabolites are likely to respond positively 
to an appropriate bioassay, however only a small percentage of them have been 
investigated for their potential value as drugs. In addition, much of the marine and 
microbial world is still unexplored, and there are plenty of bioactive compounds 
awaiting discovery in these two worlds. Besides their direct medicinal application, 
natural products can also serve as pharmacophores for the design, synthesis or semi-
synthesis of novel substances for medical uses. The discovery of natural products is also 
important as a means to further refine systems of plant classification 
[28]
. 
 
 India is one of the earliest civilizations that have recognized the importance of 
herbal products for disease management, nutrition and beauty enhancement. With the 
discovery of several new molecules from herbs for treating diseases like cancer and the 
  
relative safety of these products, the global demand for medicinal plant products has 
increased in recent years. 
 More than 30% of the pharmaceutical preparations are based on plants. An 
increasing reliance on the use of medicinal plants in the industrialized societies has been 
traced to the extraction and development of several drugs and chemotherapeutics from 
medicinal plants. Searching for new drugs in plants implies the screening the plants for 
the presence of novel compounds and investigation of their biological activities 
[29]
. 
 Many medicinal plants contain large amount of chemical components having 
broad spectrum of pharmacological activities. Anticancer activities are mainly due to 
phenolic acids, flavonoids and phenolic diterpenes. Natural products have long been a 
rich source of cure for cancer, which has been the major cause of death in the past 
decades 
[30]
. 
 
 Taxol, one of the most outstanding drug used for the treatment of metastatic 
ovarian, breast carcinoma and small cell lung cancer have been obtained from 
bark of western yew tree. 
 Etoposide ,a semi synthetic derivative of podophyllotoxin a plant glycoside 
being used in treatment of testicular tumours, lung cancer, bladder cancer. 
 Topotecan and irinotecanare two recently introduced semisynthetic analogues 
of camptothecin and antitumour principle obtained from Chinese tree. 
 Vincristine, vinblastine, colchicines and ellipticine are other important 
molecules from plant source. 
 
 Considering the toxicities which arise from cytotoxic drugs like bone marrow 
suppression, alopecia, lymphocytopenia and occurrence of secondary cancers like 
  
leukemia and lymphomas. The search further intensifies for the toxicity free herbal 
remedy for cancer, which acts by without interfering with the body's natural healing 
process 
[31]
.  
 Amaranthus spinosus Linn (Amaranthaceae), commonly known as ' Spiny 
amaranth' in India, Africa and Southeast Asia, is an important medicinal plant employed 
for different ailments in India traditionally. 
  
 Juice of Amaranthus spinosus is used by tribals of Kerala, to prevent swelling 
around stomach. The leaves are boiled without salt and consumed for 2-3 days to cure 
jaundice and also employed to cure some kind of rheumatic pain. The leaves and roots 
are applied as poultice to relief bruises, abscesses, burns, wound, inflammation, 
menorrhagia, gonorrhoea, eczema and inflammatory swelling. It is used as a sudorific, 
febrifuge, an antidote to snake poison and as a Galactagogue. It is also used in 
nutritional deficiency disorders and various other diseases in many parts of Africa. 
Amaranthus spinosus having medicinal properties like  anti-diabetic, anti-
microbial, anthelmintic, antioxidant, antihyperlipidemic, immunomodulatory, 
diuretic, analgesic and anti- inflammatory properties. 
Recent discovery of anti-cancer activity carried out by Amaranthus species 
plants (Amaranthus viridis 
[32]
, Amaranthus gangeticus 
[33]
). But there was no report for 
the evaluation of its anticancer activity in plant extract of Amaranthus spinosus. 
 Hence the present study is carried out to evaluate in vivo and in vitro anticancer 
activity of leaf extract of Amaranthus spinosus Linn. 
 
 
 
  
2 AIM AND OBJECTIVE 
 
 Successive extraction of leaf of Amaranthus spinosus by hot percolation method 
using the different solvents. 
 
 To evaluate the safety of the effective extract of Amaranthus spinosus by acute 
toxicity studies in Swiss Albino mice. 
 
 
 To evaluate the In-vitro cytotoxic activity of petroleum ether, ethyl acetate and 
ethanol extract of Amaranthus spinosus Linn. in Human Cervical Cancerous cell 
line (HeLa- Henrietta Lackes) by MTT assay. 
 
 To evaluate the In-vivo anticancer activity of effective extract of Amaranthus 
spinosus Linn. by DLA on Swiss Albino mice. 
 
 
 
 
 
 
 
 
 
 
  
3 REVIEW OF LITERATURE 
 
Review related to Amaranthus spinosus 
Antioxidant and hepatoprotective activity  
 B.S. Ashok Kumar et al.., (2010) was evaluated the hepatoprotective and 
antioxidant activity of methanolic extract of whole plant of Amaranthus spinosus 
(MEAS), against paracetamol (3g/kg p.o.) induced-liver damage in Wistar rats at dose of 
200 and 400 mg/kg respectively. In this method the hepatoprotective activity is 
determined by measuring liver marker serum enzymatic levels.The presence of amino 
acids, flavonoids and phenolic compounds in the MEAS might be responsible for its 
marked chemo protective and antioxidant activities in paracetamol induced-liver damage 
in Wistar rats 
[34]
. 
 
 Hussain Zeashan et al., (2008) has been showed hepatoprotective and 
antioxidant activity of ethanolic extract of whole plant of Amaranthus spinosus (EEAS), 
against carbon tetrachloride (CCl4) induced hepatic damage in rats. The results of this 
study strongly indicate that whole plants of A. Spinosus have potent hepatoprotective 
activity. Their study suggested that possible, hepatoprotective activity may be due to the 
presence of flavonoids and phenolics compound present in the EEAS. 
 They were also reported that antioxidant activity of Amaranthus spinosus Linn. 
by non-enzymatic haemoglycosylation. They investigated the antioxidant activity of 
different extracts by estimating the degree of non-enzymatic haemoglobin glycosylation, 
measured colorimetrically. They have been reported that rutin and quercetin showed the 
inhibition of haemoglycosylation as maximum 42% and 52%, respectively.They also 
  
reported that methanolic extract of Amaranthus spinosus leaves showed antioxidant 
activities 
[35]
. 
 
Antidiabetic activity  
 B.S. Ashok Kumar et al.., (2010) was evaluated the alpha amylase and the 
antioxidant potential of methanol extract of A. spinosus(MEAS) which exhibited in vitro 
alpha amylase enzyme inhibition by CNPG3 (2-chloro-4-nitrophenol a-D-maltotrioside) 
and in vivo antioxidant potential of malondialdehyde (MDA), glutathione (GSH), 
catalase (CAT) and total thiols (TT) in alloxan induced diabetic rats. This study provided 
evidence that the methanolic extract of A. Spinosus has potent anti-diabetic activity 
[36]
. 
 
 Shanti Bhushan Mishra et al., (2012) was evaluated anti diabetic effects of 
Amaranthus spinosus leaf extract (ASEt) against Streptozotocin-nicotinamide oxidative 
stress in albino rats. Experimental diabetes was induced by a single dose STZ (60 
mg/kg) administered by intraperitoneal way after the administration of nicotinamide 
(120mg/kg).Results clearly indicate that Amaranthus spinosus treatment attenuate 
hyperglycemia by decreasing oxidative stress and pancreatic cells damage which may be 
attributed to its antioxidative potential
[37]
. 
 
Antipyretic and antioxidant activity  
 B.S. Ashok Kumar et al., (2010) was reported the methanolic extract of 
Amaranthus spinosus leaves was screened for antioxidant and antipyretic activities. 
Antipyretic activity of methanolic extract of A. Spinosus was measured by yeast induced 
pyrexia method at concentration of 200 and 400 mg/kg using paracetamol as standard 
drug. Antioxidant activity was measured by 1,1-diphenyl-2-picryl-hydrazile (DPPH) free 
  
radical scavenging, superoxide anion radical scavenging, hydroxyl free radical 
scavenging, nitric oxide radical scavenging and total phenolic content was also 
determined
[38]
. 
 
Anti-depressant activity 
 B.S. Ashok Kumar et al., (2008) was reported the antidepressant activity of 
methanolic extract of Amaranthus spinosus (MEAS) was investigated by using Forced 
swimming test (FST) and Tail suspension test (TST) models. Escitalopam and 
Imipramine were used as reference standards. It has been observed from this study the 
MEAS at higher concentration showed significant (p<0.01) reduction in immobility in 
tail suspension and forced swim model of depression comparable to Escitalopam and 
Imipramine 
[39]
. 
 
Anthelmintic activity  
ManikBaral et al., (2010) was evaluated water extracts of whole plant of 
Amaranthus spinosus Linn for anthelmintic on adult Indian earthworms (Pheriti 
maposthuma) and Tubifex tubifex, using piperazine citrate as reference standard. 
Aqueous extract showed anthelmintic activity in dose dependent manner giving shortest 
time of paralysis (P) and death (D) with 50 mg/ml concentration, for both the worms
[40]
. 
 
Antimalarial activity 
         A. Hilou et al., (2006) was reported in vivo anti-malarial activities of extracts from 
Amaranthus spinosus L. in mice. The plant extracts showed significant anti-malarial 
activities in the 4
th
-day of suppressive anti-malarial assay in mice inoculated with red 
blood cells parasitized with Plasmodium Berghei berghei 
[41]
. 
  
 
Anti-nociceptive activity  
Hussain Zeashana et al., (2009) was studied the anti-nociceptive and anti-
inflammatory activities of 50% ethanol extract (ASE) of Amaranthus spinosus (whole 
plant). Amaranthus spinosus possessed significant and dose dependant anti-
inflammatory activity, it has also central and peripheral analgesic activity 
[42]
. 
 
Anti-inflammatory activity  
Olumayokun A. Olajide et al., (2004), wasreported that methanol extract of 
Amaranthus spinosus L. leaves exhibited anti-inflammatory activities in different animal 
models. The effect of the plant extract was also studied on castor oil–induced diarrhoea 
and gastric mucosal integrity. These results demonstrate the anti-inflammatory 
properties of the leaf extract of A. spinosus. They suggested that the plant extract 
probably acts by the inhibition of prostaglandin biosynthesis
[43]
. 
 
Heamatologic activity  
Olufemi B.E et al., (2003) has been reported that haematological effects of 
ethanol extract of Amaranthus spinosus leaf (EEAL) when administered orally to 
growing pigs to determine its effects onpacked cell volume (PCV), red blood cell (RBC) 
and white blood cell (WBC) counts, andhaemoglobin (HB) concentration. The EEAL 
significantly reduced the PCV, RBC and Hb  of pigs albeit temporarily. The final weight 
and average weight gains of the pigs weresignificantly improved with the administration 
of EEAL
[44]
. 
Ankitasrivastava et al., (2011) has been showed that alteration in 
hematocellular components of albino rats due to methanolic extract of Amaranthus 
  
spinosus. The study was carried out by single and daily administration Amaranthus 
spinosus for 5, 7 & 14 days. Results revealed that the RBC and WBC count as well as 
Hb% was significantly altered due to administration of methanolic extract of 
Amaranthus spinosus 
[45]
. 
 
Anti-diarrheal and antiulcer activity  
Zeashan Hussain et al., (2009) was showed that the ethanol extract (50%) of the 
whole plant of Amaranthus spinosus Linn. (ASE) significantly inhibited travel of a 
charcoal meal at three different doses of ASE, but when 400mg/kg of ASE was repeated 
in the presence of yohimbine, intestinal propulsive inhibition decreased, while morphine 
reversed the activity. Lipid peroxidation was also associated with a concomitant 
decrease in ulcer index
[46]
. 
 
Antigenic and allergenic activity  
Anand B. Singh et al., (2008) was reported that Amaranthus spinosus is an 
important aeroallergen in India and grows commonly in different parts of the country, 
specially significance in Type I hypersensitivity disorders. Investigated antigenic and 
allergenic properties of 5 pollen samples of Amaranthus spinosus collected from the 
Delhi area at fortnightly intervals. The observations will be helpful in standardizing 
pollen antigens for diagnosis and immunotherapy in India
[47]
. 
 
Antimicrobial activity  
Z. C. Maiyo et al., (2010) was investigated the phytochemical constituents and 
antimicrobial activity of hexane, ethyl acetate, dichloromethane and methanol leaf 
extracts of Amaranthus spinosus. The leaf extracts showed a broad spectrum anti-
  
microbial activity against Staphylococcus aureus and Bacillus spp, the gram-negative 
Escherichia coli, Salmonella typhi and a pathogenic fungus Candida albicans. It shows 
significant antimicrobial activity
[48]
. 
 
Antibacterial activity 
Harsha Vardhana S (2011) was investigated the ethanol and aqueous extracts 
of roots of Amaranthus spinosus for their antibacterial activity against ten bacterial 
strains including Gram-positive andGram-negative bacteria using the agar-well diffusion 
method. The ethanol extract presented thebest results while the aqueous extract showed 
moderate inhibition of the microbial growth
[49]
. 
 
Anti-hyperlipidemic activity  
Girija K and Lakshman K. (2011) was investigated antihyperlipidemic activity 
of methanol extracts of Amaranthus spinosus. The antihyperlipidemic effects 
investigated by using normal and triton-WR 1339 induced rats at the dose of 200, 300 
and 400mg/kg p.o. The serum harvested was analyzed for total cholesterol, triglycerides, 
high density lipoprotein and low density lipoprotein. It was found that all the three plants 
at 400mg/kg dose showed significant anti-hyperlipidemic effect, whereas 300mg/kg 
dose is less significant in the entire parameters used for evaluation of anti 
hyperlipidemic effect
[50]
. 
 
Diuretic activity  
Amuthan A, Chogtu B, Bairy KL, Sudhakar and Prakash M. (2012) was 
evaluated the diuretic activity of Amaranthus spinosus Linn. In this study different 
concentrations of aqueous extract of Amaranthus spinosus (200, 500, 1000, 1500mg/kg), 
  
thiazide (10mg/kg) and vehicle were orally administered to rats (n=6 animals per group) 
and their urine output was collected after 24h. Volume, pH, Na+, K+ and Cl- 
concentrations of urine were estimated. ASAE produced increase in Na+, K+, and Cl- 
excretion, caused alkalinization of urine, and showed strong saluretic activity and 
carbonic anhydrase inhibition activity. These effects were observed predominantly at 
500mg/kg dose and suggested that the A. Spinosus is acting as a thiazide like diuretic 
[51]
. 
 
Review related to Method-MTT assay 
 Kiranmayi. Gali et al., (2011) was determined the effective IC50 concentration 
of methanol extract of leaves of Argemone mexicana Linn, on HeLa and MCF-7 cell 
lines by MTT assay. The absorbance was read at 595nm using micro plate reader
[52]
. 
  
 T.Vithyaet al., (2012) was reported the cytotoxicity of methanolic extract of 
Sophora interrupta against HeLa and HePG2 cell lines by MTT assay. The result 
showed an IC50 value of 211.5g/ml and158.2g/ml respectively in HeLa and HePG2 cell 
lines. The MTT assay results confirmed the cytotoxicity of the plant 
[53]
. 
 
 Sanjay Patel et al., (2009) was evaluated the cytotoxicity of methanolic extract 
of Solanum nigrum against HeLa and Vero cell lines by MTT assay. Solanum nigrum 
methanolic extract showed that inhibitory action on HeLa cell line in concentration 
range between 10mg/ml to 0.0196mg/ml by using MTT assay. From the performed 
assay, methanolic extract of these drug shows greater activity on HeLa cell line that 
mean Solanum nigrum possses anticancer activity
[54]
. 
 
  
 Kanimozhi D et al., (2012) was evaluated the cytotoxicity of ethanolic extract of 
Cynodon dactylon Hela, HEP-2 and MCF-7 cell lines by MTT assay. Anticancer activity 
of ethanolic extract of Cynodon dactylon on HEP-2, HELA and MCF-7 cancer cell lines 
showed potent cytotoxic activity. The inhibition percentage with regard to cytotoxicity 
was found to be 93.5%, 88.5% and 79.2% at 10mg/ml, which was comparable to the 
control Cyclophosphamide. From the results shows Cynodon dactylon can possess 
anticancer activity 
[55]
. 
SreejamoleK L et al., (2013) was studied the cytotoxicity of ethyl acetate extract 
of Indian green mussel Perna viridis against HCT 116 and MCF 7 cell lines by MTT 
assay. The absorbance was read at 595nm using micro plate reader and the percentage 
growth inhibition was calculated 
[56]
. 
 
 SankaraAditya J et al., (2014) was studied the cytotoxicity of methanol extract 
of Durantaser ratifolia against MCF-7 and HT-29 cell line by MTT assay. To determine 
the IC50 the absorbance was taken at 592nm in a micro plate reader. Percentage of 
residual cell viability was determined 
[57]
. 
  
Review related to Method-DLA method 
 M. Devi et al., (2013) was evaluated the antitumor activity of methanolic extract 
of Decalepisha miltonii was evaluated using Dalton’s Lymphoma Ascites (DLA) tumor 
model in Swiss albino mice. The result showed that methanolic extract of Decalepisha 
miltonii root increased the mean survival time and percentage increase in life span and 
also decreased the body weight of the DLA tumor bearing mice 
[58]
. 
 
  
 Manokarankalaiselvi et al., (2012) reported the anticancer effect of Jasminum 
sambac against Dalton’s lymphoma ascites (DLA) induced Swiss albino mice in In vitro 
and In vivo model. The tumor cell proliferation inhibitory activity of methanolic extract 
showed dose dependent in both HeLa and mouse fibroblast cells. At concentrations 25-
400μg/ml, the percentage of cell inhibition concentration of normal and cancer cells was 
found to be 123.3 and 93.8μg/ml respectively.Thus it could be concluded that the 
methanolic extract of J. sambac possesses significant anticancer properties 
[59]
. 
  
 Ritika Prasad and Biplob Koch (2014) was studied the anticancer property of 
the ethanolic extract of Dendrobium formosum on Dalton’s lymphoma. The IC50 value of 
ethanolic extract was obtained at 350𝜇g/mL in Dalton’s lymphoma cells. The in vivo 
anticancer activity study illustrates significant increase in the survival time of Dalton’s 
lymphoma bearing mice on treatment with ethanolic extract when compared to control. 
These results substantiate the antitumor properties of ethanolic extract of Dendrobium 
formosum and suggest an alternative in treatment of cancer 
[60]
. 
 
 G. Anand et al., (2013) was evaluated the antitumor activity of Hydroalcoholic 
Extract of Ipomoea carnea (HAEIC) for studying anticancer activity by using both in 
vitro and in-vivo method. The In vitro anticancer activity of HAEIC was evaluated by 
the MTT assay method using Ehrlich Ascites Carcinoma (EAC) cell lines. Later the 
extract subjected to in-vivo anticancer therapy using EAC tumor model. Oral 
administration of HAEIC at the dose of 250 and 500mg/kg, significantly (p<0.001) 
increased the survival time, nonviable cell count and decrease in body weight, food 
intake and viable cell count of the tumor bearing mice. The results indicate that HAEIC 
possess significant antitumor activity on dose dependent manner
[61]
.
 
  
  
 Ramesh HA and Dinesh B Shenoy (2013) was studied the anticancer property 
of the methanolic extract of leaves of Careya arborea Roxb was on DLA model in rats 
was evaluated. Evaluation of the effect of drug response was made by the study of tumor 
growth response including increase in life span, study of hematological parameters, 
biochemical estimations. Experimental results revealed that Careya arborea Roxb 
extract possesses significant anticancer activity 
[62]
. 
  
 B. Samuel Thavamani, et al., (2014) was evaluated the anticancer activity of the 
methanol extract of Cissampelo spareira for in vitro cytotoxicity and in vivo antitumor 
activity against Dalton's Lymphoma Ascites (DLA) cells in Swiss mice. The antitumor 
effect was assessed by evaluating the packed cell volume, viable tumor cell count, 
increase in body weight, and increase in life-span. Experimental results showed the 
methanol extract ofCissampelo spareira possesses significant      anticancer agent 
[63]
. 
 
 Gopika Gopinath et al., (2015) was reported the Cytotoxic and antitumor 
activities of ethyl acetate extract of leaves of Phyllanthus acidus against Hep G2 and 
DLA cell lines. The antitumor activity of the extract was determined by using DLA cell 
line induced solid tumor model in Swiss albino mice and its comparison with anticancer 
drug cyclophosphamide. There was significant reduction of tumor volume in P. Acidus 
treated animals. The results shows ethyl acetate extract of leaves of Phyllanthus acidus 
possesses significant anticancer activity 
[64]
. 
 
 Purushoth Prabhu. T et al., (2011) was studied the anticancer property of the 
ethanolic extracts of Canthium parviflorum for in vitro cytotoxicity and in vivo 
  
antitumor activity against Dalton's Lymphoma Ascites (DLA) cells in Swiss mice. In 
this study shows a significant increase in the life span and a decrease in the cancer cell 
number & tumour weight were noted in the tumor induced mice after treatment with 
Canthium parviflorum. Experimental results revealed that Canthium parviflorum extract 
possesses significant anticancer activity 
[65]
. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
PLANT PROFILE 
Figure No:  1  Amaranthus spinosus Linn. 
 
 
 
Figure No: 2 Leaves of Amaranthus spinosus Linn. 
 
  
Amaranthus spinosus Linn. 
Synonym          : Spiny amaranth 
Biological source          : Amaranthus spinosus 
Family               :Amaranthaceae 
Regional names 
[66] 
 English : Prickly Amaranth, Spiny amaranth, Thorny amaranth  
 Hindi : Kantachaulai,  
Tamil            :           Mullukkeerai 
Gujarati : Kantalodhimdo, Kantanudant 
Malayalam : Kattumullenkeera 
Telugu : Mullatotakura 
Kannada : Mulluharivesoppu 
Bengali : Kantanotya 
Oriya : Kantaneutia 
Sanskrit : Tanduliuyah 
Taxonomy  
Kingdom :  Plantae  
Division : Magnoliophyta 
Class  : Magnoliopsida 
Order : Caryophyllales 
Family : Amaranthaceae 
Genus : Amaranthus 
Species : spinosus 
  
Origin and Distribution  
 Amaranthus spinosus has spread through tropical and subtropical latitudes 
around the world. It is an annual plant growing to 0.6 m that is widely distributed in the 
humid zone. The plant grows wild in cultivated fields, waste places, roadsides, garbage 
heaps and abandoned fields. It will grow both in wet or dry sites, but grows best when 
soil moisture levels are below field capacity. It is being commercially cultivated in West 
Bengal, Maharashtra and Tamil Nadu. 
Description of the Plant  
 A. spinosus is an erect, multi-branched, smooth, herbaceous annual growing to 
120cm. Stems angled or with longitudinal lines or ridges, green or brown, leaves 
alternate, broadly lanceolate to ovate, discolorous, conspicuously veined beneath, up to 
7cm long, 4cm wide, margins entire, the base tapering to the slender petiole up to 7cm 
long, with a pair of straight spines up to 1cm long at the base. Inflorescences long, 
slender, terminal, with ancillary spikes in clusters, greenish; flowers unisexual, straw-
coloured, perianth segments fine, acuminate, upper third of spike being male with five 
stamens each, lower two-thirds female with three, rarely two, styles to the ovary, fruit 
one-seeded, opening by a line around the centre, seeds reddish-brown, lens-shaped, 
shiny.The striated, often reddish, stem with two sharp, long spines at the base of the 
petioles, and the fruit which opens by a line around the centre are distinguishing 
characteristics of this species
[67]
. 
Chemical constituents  
           The plant has been reported to contains Glycosides, Flavonoids, Sterols and 
triterpenoids.Leaves and stems contain n-alkanes, hentriacontane, octacosanoate, sterols 
including a-spinasterol, fatty acids, free alcohols, proteins and mixture of saponins, 
  
composed of oleanolic acid, D-glucose and D-glucoronic acid. It contains 7-p- 
coumaroylapigenin 4-O- beta-D-glucopyranoside, a new coumaroyl flavone glycoside 
called spinoside. It is a good source of calcium, also contains phosphorous, iron, 
nicotinin acid, ascorbic acid and protein. Roots contain a-spinasterol, octacosanoate and 
a number of saponins, ß-sitosterol, stigmasterol, campesterol and cholesterol, stearic, 
oleic and linoleic acids, quercetin and rutin also isolated from the plant 
[68]
. 
Uses  
 Cosmetics, Dyes and Colouring agent. 
 Yellow and green dyes can be obtained from the whole plant. 
 A red pigment obtained from the plant is used as colouring in foods and 
medicines. 
Medicinal uses  
 Amaranthus spinosus has many medicinal properties like astringent, diaphoretic, 
diuretic, emollient, febrifuge, galactogogue etc. 
 Amaranthus spinosus used in the treatment of internal bleeding, diarrhoea, 
excessive menstruation 
 It is also used in the treatment of snake bites. 
 Externally, it is used to treat ulcerated mouths, nosebleeds and wounds 
 The root is emmenagogue and galactogogue. A paste of the root is used in the 
treatment of menorrhagia, gonorrhoea, eczema and colic 
 The juice of the root is used to treat fevers, urinary troubles, diarrhoea and 
dysentery
[69]
.                                                                                                                
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5 MATERIALS AND METHODS 
5.1 PLANT COLLECTION  
 The plant Amaranthus spinosus was collected from Institute of Siddha College, 
Thirunelveli, in November 2015. The plant material was identified and authenticated by 
Mr. V. Chelladurai, Research Officer -Botany (retd.), Central Council for Research in 
Ayurveda & Siddha, Govt. of India. 
Instruments used during the course of study  
 Soxhlet apparatus 
 Co2 Incubator 
 Cooling centrifuge 
 Haemocytometer 
 Inverted microscope 
 UV- Spectrophotometer 
 All biochemical investigation was done by using COBAS MIRA PLUS-S Auto 
analyzer from Roche Switzerland. 
 Haematological tests are carried out in COBAS MICROS OT 18 from Roche 
 Newly added Hi-Tech instruments MAX MAT used for an auto analyzer for all 
biochemistry investigations in blood sample. 
 
5.2 Preparation of extract 
        The plant was shade dried at room temperature and was subjected to size 
reduction to a coarse powder by using dry grinder. 60grams of this coarse powder 
was packed in to soxhlet apparatus and was subjected to extraction sequentially with 
500ml of petroleum ether followed by ethyl acetate and ethanol. 
  
  The extraction was continued until the colour of the solvent in the siphon tube 
become colourless. Extraction procedure was carried out in Institute of 
Pharmacology, Madras Medical College, Chennai-03. Extracts of pet ether, ethyl 
acetate and ethanol were subjected to evaporation by Rotary evaporator at below 
60ºc. The percentage yield from the Amaranthus spinosus using different 
solvents is given as below Table 1. 
 
Table No 1: Percentage yield from the plant Amaranthus spinosus using               
different solvents. 
Extracts 
 
Plant material used for       
Extraction (g) 
Yield (g) Percentage Yield 
(%) 
Petroleum ether 60 1.5 2.40 
Ethyl acetate 60 4.0 6.50 
Ethanol 60 9.5 15.80 
 
 
METHODOLOGY 
5.3 IN-VITRO ANTICANCER ACTIVITY 
 The anticancer activity of Amaranthus spinosus Linn was evaluated by MTT 
assay against Human cervical cancer cell line (HeLa). 
Materials required  
 96 well micro titre  plate 
 Fully grown/confluency reached cell in culture flask 
 Minimum essential medium with 10% FBS  
 TPVG solution 
 Plant extract- Ethanol, Ethyl acetate, Petroleum ether 
  
 MTT (5mg/ml in PBS-pH7.4) 
 DMSO solution (0.1% v/v) 
 Aluminium foil  
 Micropipette 
 Inverted microscope 
 Reagent bottle 
 Bio safety cabinet 
 Tryptan blue 
 UV- chamber 
 CO2 incubator 
 
  Cell line  
  The human cervical cancer cell line (HeLa) was obtained from National Centre 
for Cell Science (NCCS), Pune and grown in Eagles Essential Medium containing 
10% fetal bovine serum (FBS).  
   The cells were maintained at 37ºC, 5% CO2, 95% air and 100% relative 
humidity. Maintenance cultures were passages weekly and the culture medium was 
changed twice a week. 
 
Cell treatment procedure  
 The monolayer cells were detached with trypsin-ethylene diamine tetra 
acetic acid (EDTA) to make single cell suspension and viable cells were 
counted using a hemocytometer and diluted with medium containing 5% 
FBS to give final density of 1×10
5
cells/ml. 
  
 One hundred micro litres per well of cell suspension were seeded into 96-
wellplates at plating density of 10,000 cells/well and incubated to allow for 
cell attachment at 37ºC, 5% CO2, 95% air and 100% relative humidity. 
 
 After 24hr the cells were treated with serial concentration of the test 
samples. They were initially dissolved in neat dimethylsulfoxide (DMSO) 
and an aliquot of the sample solution was diluted to twice the desired final 
maximum test concentration with serum free medium. 
 
 
 Additionally four serial dilutions were made to provide a total of five 
sample concentrations. Aliquots of 100µl of these different sample dilutions 
were added to the appropriate wells already containing 100µl of medium, 
resulting in the required final sample concentrations. Following sample 
addition, the plates were incubated for an additional 48hr at 37ºC, 5%CO2, 
95% air and 100% relative humidity. The medium containing without 
samples were served as control and triplicate was maintained for all 
concentrations. 
 
MTT assay  
     It is otherwise called as tetrazolium salt assay or Microculturetetrazolium test. 
MTT assay is an in-vitro method for screening, which has been internationally 
accepted. 3-[4,5- dimethylthiazol-2-yl] 2,5-diphenyl tetrazolium bromide (MTT) is a 
yellow water soluble tetrazolium salt. A mitochondrial enzyme in living cells, 
succinate-dehydrogenase, cleaves the tetrazolium ring, converting the MTT to an 
  
insoluble purple formazan. Therefore, the amount of formazan produced is directly 
proportional to the number of viable cells. 
       The cytotoxicity of samples on Chang Liver cells was determined by the 
MTT assay (Mosmann et al.,1983). Cells (1 × 10
5
/well) were plated in 5ml of 
medium/well in 24-well plates (Costar Corning, Rochester, NY). After 48 hours 
incubation the cell reaches the confluence. Then, cells were incubated in the presence 
samples for 24 - 48h at 37°C. After removal of the sample solution and washing with 
phosphate-buffered saline (pH 7.4), 1ml/well (5mg/ml) of 0.5% 3-(4,5-dimethyl-2-
thiazolyl)-2,5-diphenyl-- tetrazolium bromide cells(MTT) phosphate- buffered saline 
solution was added. After 4h incubation, 0.04M HCl/ isopropanol was added.  
 Viable cells were determined by the absorbance at 570nm. Measurements were 
performed and the concentration required for a 50% inhibition of viability (IC50) was 
determined graphically. The absorbance at 570 nm was measured with a UV- 
Spectrophotometer using wells without sample containing cells as blanks. The effect 
of the samples on the proliferation of Chang Liver cells was expressed as the % cell 
viability, using the following formula:  
             % cell viability = A570 of treated cells / A570 of control cells × 100% 
 Linear regression graph was plotted between % cell viability and Log 
concentration. The IC50 was determined by using graphical method. 
 
 
 
 
 
  
5.4 IN- VIVO ANTICANCER ACTIVITY 
      The anticancer activity of Amaranthus spinosus Linn was evaluated in Swiss 
albino mice. Tumor was induced by intra-peritoneal injection of (1x10
6
) Dalton's 
Lymphoma Ascites (DLA) cells. The anticancer effect of plant extract was 
compared with standard drug 5- fluorouracil at 20mg/kg body weight. 
 
Materials required  
 Dalton's Lymphoma ascites (DLA) cells 
 Mice (20-25gm) 
 Ethanolic extract of Amaranthus spinosus (EEAS) 
 Tryphan blue 
 Sterile Phosphate Buffer Solution  
 Ice cold Normal saline 
 5-flurouracil (20mg/kg) 
 Cooling centrifuge 
 Insulin syringe 
 5% formaldehyde 
 Haematoxylin 
 Micro nylon boxes 
 
Experimental procedure  
Selection, Grouping and Acclimatization of Laboratory Animal
[70] 
 Male Swiss albino mice (20-25gm) were produced from animal 
experimental laboratory and used throughout the study .They were housed in micro 
  
nylon boxes in a control environment (temp 25+2ºC) and 12 hr dark/light cycle with 
standard laboratory diet and water ad libitum.  
         All animal procedures were performed after approval from the Institutional 
ethical committee. The experimental protocol has been approved by Institutional ethical 
committee, Madras Medical College, Chennai. IAEC/MMC/07/243/CPCSEA/2015-16.  
As per the standard practice, the mice were segregated based on their gender and 
quarantined for 15 days before the commencement of the experiment. They were fed on 
healthy diet and maintained in hygienic environment in our animal house. 
 
Technique for Inducing Tumor 
             Various technique for induction of cancer in animals via, chemically 
induced (using DMBA/croton oil, etc)
[71]
 virus induced, cell line induced (sarcoma-180, 
ULCA fibro sarcoma and Jensen sarcoma, mouse lung fibroblast cells L-929, Dalton's 
Lymphoma Ascitic (DLA), Ehrlich Ascites Carcinoma (EAC)
[72,73,74]
 methods have been 
used in experimental studies of anticancer activity. 
      In the present study, cell lines induced cancer in mice was used to evaluate 
the anticancer activity of ethanolic extract of Amaranthus spinosus Linn. (EEAS). 
 
EVALUATION OF ANTICANCER ACTIVITY  
Induction of cancer using DLA cells  
Dalton's Lymphoma Ascitic (DLA) cells were supplied by Amala cancer 
research centre, Trissur, Kerala, India. The cells are maintained in Swiss albino mice by 
intraperitoneal transplantation. While transforming the tumor cells to the grouped animal 
the DLA cells were aspirated from peritoneal cavity of the mice using saline.  
  
The cell counts were done and further dilutions were made so that total cell 
should be 1×10
6
, this dilution was given intraperitoneally. Let the tumor grown in the 
mice for minimum seven days before starting treatments. 
 
Treatment Protocol 
[75] 
Swiss Albino mice were divided into five group of six each. All the animals in four 
groups were injected with DLA cells (1×10
6
cells per mouse) intraperitoneally and the 
remaining one group is normal control group. 
 
Table No: 2 Grouping of Animals and Treatment Schedule 
 
 
S.NO 
 
GROUP 
 
TREATMENT SCHEDULE 
 
1 
 
Group – 1 
 
Served as the normal control 
 
2 
 
Group – 2 
 
Served as the tumor control. Group 1 and 2 receives normal 
diet and water. 
 
3 
 
 
Group –3 
 
Served as the positive control, was treated with injection of 
5-fluorouracil at 20mg/kg body weight, intraperitoneally.  
 
4 
 
Group –4 
 
Served as treatment control received (200mg/kg.bw) EEAS 
administered through orally. 
 
5 
 
Group – 5 
 
Served as treatment control received (400mg/kg.bw) EEAS 
administered through orally. 
 
 
 
 
 
 
  
Treatment  
 In this study, drug treatment was given after the 24hr of inoculation, once daily 
for 14 days. On day 14, after the last dose, all mice from each group were sacrificed by 
euthanasia. Blood was withdrawn from each mouse by retro orbital puncture blood 
collecting method. From the collected blood haematological parameters were checked, 
the remaining blood was centrifuged and serum was used for the estimation of 
biochemical parameters. 
 
Haematological parameters    
 WBC count 
 RBC count 
 Hb content 
 Platelet count 
 Packed cell volume 
Serum enzyme and lipid profile  
 Total Cholesterol (TC) 
 Triglycerides (TG) 
 Aspartate amino Transferase (AST) 
 Alanine amino Transferase (ALT) 
 Alkaline Phosphatase (ALP) 
 Derived parameters  
 Body weight 
 Life span (%) 
 Cancer Cell Count 
  
Determination of percentage Increase of Life Span (ILS)
[76]
 
               In this study, drug treatment was given after the 24hr of inoculation, once 
daily for 14 days. The animals were monitored daily twice for 30 days. Antitumor effect 
of Amaranthus spinosus was determined by monitoring the death pattern of animals due 
to tumor burden and calculating the percentage increase in life span (%ILS). The 
percentage increase in life span was calculated using the following formula: 
 
   ( )  
                          
                          
       
 
Determination of Average Body weight changes  
The body weight (BW) of the control and treated group animals were measured 
from 0th day to 30th day interval up to 30 days. 
Cancer cell count 
    The fluid (0.1ml) from the peritoneal cavity of each mouse was withdrawn by 
sterile syringe and diluted with 0.8ml of ice cold normal saline or sterile Phosphate 
buffer Solution and 0.1ml of tryphan blue (0.1mg/ml) and total numbers of the living 
cells were counted using haemocytometer. 
 
        Cell count = No. of cells Dilution/Area × Thickness of liquid film 
 
 
 
 
 
  
Histopathological analysis  
A small portion of liver was taken and fixed in to 5% formaldehyde, after several 
treatments for dehydration in alcohol, sections having 4µm thickness were cut and 
strained with haematoxylin and eosin and histopathological analysis was carried out for 
the treated as well as control group of mice. 
 
Statistical analysis    
  Values are expressed as mean (±SEM). The statistical analysis was performed 
using one-way analysis of variance (ANOVA) followed by Dunnett test using Graph pad 
In Stat version 3.0, Graph Pad Software, San Diego, California< USA. P-Values (i.e., 
*p<0.05, **P<0.01) were considered statistically significant compared to DLA tumor 
control. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
6 RESULTS 
 
MTT assay  
MTT assay carried out with petroleum ether, ethyl acetate and ethanol extract of 
Amaranthus spinosus and the results was shown in the following tables. 
Table No 3:  IC50 concentration and % cell viability of ethanolic extract of 
Amaranthus spinosus 
S. No 
Concentration 
(µg/ml) 
Dilutions 
Absorbance 
(O.D) 
Cell Viability 
(%) 
1 1000 Neat 0.02 3.17 
2 500 1:1 0.07 11.11 
3 250 1:2 0.12 19.04 
 4 125 1:4 0.16 25.39 
5 62.5 1:8 0.22 34.92 
6 31.2 1:16 0.29 46.03 
7 15.6 1:32 0.33 52.38 
8 7.8 1:64 0.39 61.90 
9 Cell control - 0.63 100 
 
 
 
 
 
 
 
 
 
 
  
 
Fig. No 3: % Cell viability Vs Concentration in µg/ml of ethanolic extract of 
Amaranthus spinosus 
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Table No 4: IC50 concentration and % cell viability of Ethyl acetate extract of 
Amaranthus spinosus 
S.No Concentration 
(µg/ml) 
Dilutions Absorbance 
(O.D) 
Cell Viability 
(%) 
1 1000 Neat 0.08 12.69 
2 500 1:1 0.14 22.22 
3 250 1:2 0.20 31.74 
 4 125 1:4 0.25 39.68 
5 62.5 1:8 0.31 49.20 
6 31.2 1:16 0.36 57.14 
7 15.6 1:32 0.41 65.07 
8 7.8 1:64 0.44 69.84 
9 Cell control - 0.63 100 
 
 
Fig. No 4: % Cell viability Vs Concentration in µg/ml of Ethyl acetate extracts of 
Amaranthus spinosus 
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Table No 5: IC50 concentration and % cell viability of Petroleum ether extract of 
Amaranthus spinosus 
S. No Concentration 
(µg/ml) 
Dilutions Absorbance 
(O.D) 
Cell Viability 
(%) 
1 1000 Neat 0.05 7.93 
2 500 1:1 0.09 14.28 
3 250 1:2 0.15 23.80 
 4 125 1:4 0.19 30.15 
5 62.5 1:8 0.23 36.50 
6 31.2 1:16 0.27 42.85 
7 15.6 1:32 0.32 50.79 
8 7.8 1:64 0.37 58.73 
9 Cell control - 0.63 100 
 
 
Fig. No 5: % Cell viability Vs Concentration in µg/ml of Petroleum ether extract of 
Amaranthus spinosus 
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In- vitro cytotoxicity study of Amaranthus spinosus 
 
Anticancer effect of Ethanol extract on HeLa Cell line 
Fig. No: 6a Normal HeLa Cell line 
 
 
Fig. No: 6b Toxicity-1000µg/ml             Fig. No: 6c Toxicity- 125µg/ml 
   
    
 
Fig. No: 6d Toxicity-62.5µg/ml  Fig. No: 6e Toxicity- 31.2µg/ml 
    
 
 
 
 
 
 
  
Anticancer effect of Ethyl acetate extract on HeLa Cell line 
Fig. No: 7a Normal HeLa Cell line 
 
 
Fig. No: 7b Toxicity-1000µg/ml                     Fig. No: 7c Toxicity-125µg/ml 
 
 
 
Fig. No: 7d Toxicity-62.5µg/ml  Fig. No: 7e Toxicity- 31.2µg/ml 
   
  
 
Anticancer effect of Petroleum Ether extract on HeLa Cell line 
 
Fig. No: 8a Normal HeLa Cell line 
 
 
Fig. No: 8b Toxicity-1000µg/ml Fig. No: 8c Toxicity-125µg/ml 
 
 
Fig. No: 8d Toxicity-62.5µg/ml Fig. No: 8e Toxicity- 31.2µg/ml 
 
 
 
 
 
 
  
IN- VIVO ANTICANCER ACTIVITY 
Evaluation of clinical parameters 
 Hematological parameters 
i) WBC count 
ii) RBC count 
iii) Platelet count 
iv) Haemoglobin 
v)  Packed Cell Volume 
i) WBC count 
 The total WBC count was found to be increased in cancer control, when compared 
with normal and treated tumor-bearing mice. 
[77]
 
ii) RBC and Hb 
 RBC and Hb content decreases with tumor bearing mice when compared with 
Normal control mice. 
iii) Platelets 
 In Hodgkin lymphoma, increased in platelet count often reported in laboratory 
finding
[78]
.  
iv) Packed cell volume  
In any case of anaemia the packed cell volume is decreases.  
 
 
 
 
  
 
Table No 6: Effect of EEAS on Hematological parameters 
 
G1 – Normal Control, G2 – Cancer Control, G3 – Positive control, G4 – Treatment 
control (200mg/kg)   G5 – Treatment control (400mg/kg) 
All values are expressed as mean ± SEM for 6 animals in each group. 
**a – Values are significantly different from normal control (G1) at P < 0.001 
**b – Values are significantly different from cancer control (G2) at P < 0.01 
 
 
SERUM ENZYME AND LIPID PROFILE 
The serum was analyzed for the following parameters 
(a) Aspartate amino Transferase (AST) 
(b) Alanine amino Transferase    (ALT) 
(c) Alkaline Phosphatase             (ALP) 
(d) Total Cholesterol                    (TC) 
(e) Triglyceride                            (TG) 
 
1. TOTAL CHOLESTEROL AND TRIGLYCERIDE (lipid profile) 
 Abnormal blood lipid profile has been associated with cancer. In Hodgkin 
lymphoma, high cholesterol level and low triglyceride level has been reported 
[79] 
Treatment 
Total WBC 
Cells /mlx10
3 
RBC 
Count 
Mill/cum 
Hb 
Gm/dl 
PCV % 
Platelets 
Lakhs/cum 
G1 10.30 ±1.26 4.32±0.90 12.35 ±1.30 14.20±2.40 3.28±0.75 
G2 16.20 ±2.98
a** 
2.25±0.50
a** 
6.15  ±0.90
a** 
36.30±3.30
a** 
1.02±0.55
a** 
G3 13.25 ±1.95
b** 
3.95±1.40
b** 
11.27±1.50
b** 
16.45±1.45
b** 
2.98±0.92
b** 
G4 14.30 ±1.80
b** 
4.03±0.62
b** 
12.09±1.35
b** 
20.62±2.35
b** 
3.02 ±0.66
b** 
G5 14.20±2.01
b** 
4.15±0.35
b** 
12.25±1.65
b** 
18.70±2.30
b** 
3.25±0.75
b** 
  
. 
1. LIVER ENZYMES (AST, ALT, ALP) 
 Abnormal liver function seen in patient with Hodgkin lymphoma that these liver 
enzyme levels markedly increase in tumor bearing mice. ALP is an enzyme mainly 
derived from the liver, bones and in lesser amount from intestines, placenta, kidneys and 
leukocytes. An increase in ALP levels in the serum is frequently associated with the 
variety of disease
. [80]
 ALP comprises a group of enzyme that catalyzes the phosphate 
esters in an alkaline environment, generating an organic radical and inorganic phosphate. 
 Markedly elevated serum ALP, hyperalakline-phosphatasemia, is seen 
predominantly with more specific disorders; including malignant biliary cirrhosis, hepatic 
lymphoma and sarcoidosis
[81]
. 
 
Table No7: Effect of EEAS on serum Enzymes and lipid proteins 
 
G1 – Normal Control, G2 – Cancer Control, G3 – Positive control, G4 – Treatment 
control (200mg/kg) G5 – Treatment control (400mg/kg) 
All values are expressed as mean ± SEM for 6 animals in each group. 
**a – Values are significantly different from control (G1) at P < 0.001 
**b – Values are significantly different from cancer control (G2) at P < 0.001 
 
 
 
 
Treatment 
Cholesterol 
(mg/dl) 
TGL 
(mg /dl) 
AST 
(U/L) 
ALT 
(U/L) 
ALP 
(U/L) 
G1 110.05±3.45 134.80±2.50 38.45 ±1.62 33.30 ±1.40 130.30 ±2.35 
G2 142.90±4.25
a** 
228.30±4.45
a** 
74.4±2.70
a** 
60.30±2.65
a** 
258.35±4.30
a** 
G3 128.32±3.80
b** 
162.10±2.62
b** 
46.45 ±1.70
b** 
32.50±1.65
b** 
175.40±2.36
b** 
G4 114.25±2.60
b** 
170.35±2.50
b** 
48.40±1.95
b** 
38.38 ±1.70
b** 
194.35±2.50
b** 
G5 112.20±3.02
b** 
166.60±2.70
b** 
40.50 ±2.10
b** 
35.22±1.95
b** 
196.32±2.12
b** 
  
DERIVED PARAMETERS 
 
 
1. Body weight 
 
 All the mice were weighed, from the beginning to 15
th
 day of the study. Average 
increase in body weight on the 15
th
 day was determined. 
 
2. Percentage increase in life span (ILS) 
 % ILS was calculated by the following formula 
 %ILS = 100x1
groupcontrolofspanLife
grouptreatedofspanLife
    
 
Table No 8: Effect of EEAS on the life span, body weight and cancer cell count of 
tumor induced mice. 
Treatment Number of 
animals 
% ILS Life 
span 
Increase in 
Body weight 
grams 
Cancer cell 
count 
ml X 10
6
 
G1 6 >>30 days 2.20±0.55 - 
G2 6 48% 9.60±0.90
a**
 2.70±0.40
a**
 
G3 6 94% 5.85±0.50
b**
 1.15±0.35
b**
 
G4 6 79% 6.40±0.72
b**
 1.50±0.45
b**
 
G5 6 86% 5.95±0.88
b**
 1.42±0.28
b*
 
 
G1 – Normal Control, G2 – Cancer Control, G3 – Positive control, G4 – 
Treatment control (200mg/kg) G5 – Treatment control (400mg/kg) 
All values are expressed as mean ± SEM for 6 animals in each group. 
**a – Values are significantly different from control (G1) at P < 0.001 
**b – Values are significantly different from cancer control (G2) at P < 0.001 
 
 
  
HISTOPATHOLOGICAL STUDIES 
Fig. No 9: Normal control group treated with 10ml/kg of 
normal saline 
 
 
 
 
 Section shows Structure of Liver with sheets of Hepatocytes Separated by 
Sinusoids Cartial Vein and Portal tract appear normal. 
Fig. No: 10 Cancer control group (Tumor control) 
 
 
 
  Section shows structure of liver with cords of hepatocytes and small area of 
lymphmatous cells.  
  
 
Fig. No: 11 Positive control (5-fluorouracil)  
 
 
 
 
 
 
 
Structure of liver with cords of hepatocytes with reduced lymphmatous cells. 
 
 
Fig. No: 12 Treatment control received 200mg/kg of EEAS 
 
 
 
 
 
A section shows liver parenchyma with decreased inflammatory cells.
  
Fig.No: 13 Treatment control 400mg/kg of EEAS 
 
 
 
 
 
 
A section shows liver parenchyma with cords of hepatocytes, No lymphmatous cells. 
 
 
 
 
HISTO PATHOLOGICAL OBSERVATIONS
[82]
 
 
 
Histology of liver sections of normal control animals (Group I) showed normal 
liver architecture with were brought out central vein, were preserved cytoplasm and 
prominent nucleus and nucleolus (Fig no: 9). The liver sections of DAL treated animals 
(Group II) showed hepatic cells with serum toxicity characterized by inflammatory cell 
collection, scattered inflammation across liver parenchyma, focal necrosis and swelling 
up of vascular endothelial cells (Fig no: 10). 
 
5FU (Group-III) exhibited protection from DAL cell line induced changes in the 
liver (Fig no: 11). EEAS pretreatment at a dose of 200mg and 400mg/kg (group IV and 
V) appeared to significantly prevent the DAL toxicity as revealed by the hepatic cells 
with were preserved cytoplasm. EEAS pretreatment also caused marked decrease in 
inflammatory cells (Fig no: 12 and 13). 
 
  
7 DISCUSSION 
 Cancer is considered as a serious health problem worldwide. Tumor is a mass of 
tissues which proliferative, spread throughout the body and may eventually cause death 
of the host
[83]
. With increase in mortality rates among patients suffering from cancer with 
limited success being achieved in clinical therapies including radiation, chemotherapy, 
immune modulation and surgery in treating cancer patients, there arises a need for new 
way for cancer management. 
 Natural phytochemicals derived from medicinal plants have attained a greater 
significance in potential management of several diseases including cancer. Several 
researches have been carried carcinogenic causes 
[84]
. 
 Discovery of very effective herbs and elucidation of their underlying mechanisms 
could lead to development of an alternative and complimentary method for cancer 
prevention and treatment. Medicinal plants constitute a common alternative for cancer 
prevention and treatment in many countries around the world. Currently more than 3000 
plants around the world have been reported to possess anticancer property 
[85]
. 
 Screening of different plant components in search of anticancer drugs is one of 
the main research activities throughout the world. Vinca alkaloids and cytotoxic 
podophyllotoxins were discovered in the 1950s as first anticancer agents from plants 
[86]
.                                                                                                                                                                                                                 
 Amaranthus spinosus are traditionally used as cosmetics, dyes and colouring 
agent and medicinally used to treat diabetes mellitus, diuretic, internal bleeding, 
anthelmintic, anti-pyretic and anti- inflammatory etc. 
 The Phytochemical analysis of ethanolic extract of leaves of Amaranthus 
spinosus revealed the presence of flavonoids, terpenoids, glycosides, tannins, steroids 
and carbohydrates. The ethyl acetate and petroleum ether extracts didn't show the 
  
presence of flavonoids and glycosides. The ethanolic extracts revealed the presence of 
flavonoids and glycosides which shows that it may anticancer activity and destroy cancer 
cells.                                                                                                                                                                                                                                                                                                                                                      
In-vitro cytotoxicity assay  
 Dried leaf part of Amaranthus spinosus were extracted with solvents like 
Petroleum ether, Ethyl acetate and Ethanol. In-vitro cytotoxic activity was carried out in 
Human Cervical Cancer cell line (HeLa) with extracts of Petroleum ether, Ethyl acetate 
and Ethanol. Test for cytotoxicity was carried out by MTT assay. Among the three 
extracts evaluated, the effective extract was found to be Ethanol extract with IC50 value 
of 15.6µg/ml followed by ethyl acetate and petroleum ether with IC50 value of 62.5µg/ml 
and 15.6µg/ml respectively. Linearity was expressed with help of graph plotted in 
Microsoft excel.  
 By carrying out MTT assay ethanol extract was found to be more effective of all 
three extracts and further studies carried out with ethanol extract. Acute toxicity studies 
were carried out by using Swiss albino mice at dose level up to 2000mg/kg. 
In-vivo anticancer activity 
 In-vivo anticancer study was carried out by using Dalton's Ascetic Lymphoma 
cells inducing cancer in Swiss albino mice. 
Effect on Tumor Growth  
 In the DLA tumor control group, the average life span of animal was found to be 
48% whereas ethanolic extract of Amaranthus spinosus Linn. at a dose of 200mg/kg and 
400mg/kg body weight increase the life span to 79%, and 86% respectively. These values 
were significant. However the average life span of 5-FU treatment was found to be 94%, 
indicating its potent antitumor nature. The antitumor nature of ethanolic extract of 
  
Amaranthus spinosus Linn. at a dose of 200 and 400 mg/kgwas evidenced by the 
significant reduction in percent increase in body weight of animal treated with ethanolic 
extract of Amaranthus spinous Linn. at a dose of 200 and 400 mg/kg body weight when 
compared to DLA tumor bearing mice.  
 It was also supported by the significant reduction in packed cell volume and 
viable Tumor cell count in ethanolic extract of Amaranthus spinosus Linn at a dose of 
200mg/kg and 400mg/kg treatments when compared to the DLA tumor control. (Table 
No:8). 
Effect on Hematological Parameters 
 As shown in (Table No: 6) RBC, Hb, Platelets were decreased and WBC count 
was significantly increased in the DLA control group compared to the normal control 
group. Treatment with ethanolic extract of Amaranthus spinosus Linn. at a dose of 200 
and 400 mg/kg significantly increases the Hb content, RBC, Platelets and significantly 
decreased the WBC count to normal level. All these results suggested the anticancer 
nature of the ethanolic extract of Amaranthus spinosus Linn. at a dose of 200 and 400 
mg/kg. However, the standard 5FU at the dose of 20 mg/kg body weight produced better 
result in all these parameters. 
Effect on Biochemical Parameters 
 The inoculation of DLA cellscaused significantly increase in the level of Total 
Cholesterol, Aspartate amino Transferase, Alanine amino Transferase, Alkaline 
Phosphatase in the tumor control animals(G2), when compared to the normal group. The 
treatment with ethanolic extract of Amaranthus spinosus Linn. at a dose of 200 and 400 
mg/kg body weight reversed these changes towards the normal level. (Table No: 7) All 
  
the value was found to be significant. The treatment with standard 5-FU also gave similar 
results. 
Effect on Histopathology  
 The histopathological observation of liver section of normal, DLA tumor control,  
standard drug 5-fluorouracil and extract treated animals collected at the end of the 
experimental periods (i.e., Day 30 after DLA intraperitoneal injection) were shown in 
Fig. No: 13. Normal untreated animals section shows structure of Liver with sheets of 
Hepatocytes separated by Sinusoids Cartial Vein and Portal tract appear normal. DLA 
induced Section shows structure of liver with cords of hepatocytes and small area of 
lymphomatous cells. However, mice treated with Amaranthus spinosus and 5-
fluorouracil showed no lymphomatous cells. Histopathological examination showed a 
protective effect of Amaranthus spinosus on hepatotoxicity. 
 In DLA tumor bearing mice, a regular rapid increase in ascetic tumor volume was 
observed. Ascitic fluid is the direct nutritional source for tumor cells and a rapid increase 
in ascitic fluid with tumor growth would be a means to meet the nutritional requirement 
of tumor cells
[87]
. 
 Treatment with Amaranthus spinosus inhibited the tumor volume, viable tumor 
cell count and increased the life span of the tumor bearing mice. The reliable criteria for 
judging the value of any anticancer drug are the prolongation of the life span of 
animals
[88]
. 
 
 
 
 
  
 
8. CONCLUSION 
 
 In-vitrostudies by MTT assay, the ethanol extract of Amaranthus spinosus L. was 
found to be effective, which shows viability 50% of cell growth at concentration 
in 15.6µg/ml. 
 The ethanolic extract of Amaranthus spinosus L. (200mg/kg and 400mg/kg) 
exhibited significant reduction in packed cell volume and viable Tumor cell count 
and also increase the life span of cells in DLA induced tumor mice. 
 In- vivo studies of Amaranthus spinosus L. ethanolic extract revealed by 
enhancing the survivability of the tumor bearing mice. Thus it was concluded that 
the ethanol extract of Amaranthus spinosus L. has antitumor activity. 
 
 On the basis of the above result it was suggested that, the In-vitro and In-vivo 
anticancer activity of ethanolic extract of Amaranthus spinosus leaves possessed 
significant anticancer effect. This may probably due to the presence of phytochemicals 
such as phenols, terpenoids and flavonoids. Further isolation and purification of bioactive 
compound from Amaranthus spinosus may reveal the presence of potent novel anticancer 
agent and also to unveil the molecular mechanism behind its therapeutic action. 
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